Expedient five-step synthesis of SIB-1508Y from natural nicotine

Journal of Organic Chemistry

Volumn 71, Issue 22, 2006, Pages 8673-8675

  Wagner, Florence F ^a   Comins, Daniel L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC COMPOUNDS; DISEASE CONTROL; STEREOCHEMISTRY; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

ALTINICLINE; NATURAL NICOTINE; PYRIDINE RINGS; REGIOSELECTIVE SUBSTITUTION;

NITROGEN COMPOUNDS;

3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE; ALTINICLINE; ANTIPARKINSON AGENT; NICOTINE DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; HALOGENATION; LITHIATION; PARKINSON DISEASE; REDUCTION;

ANTIPARKINSON AGENTS; MOLECULAR STRUCTURE; NICOTINE; PYRIDINES; PYRROLIDINES; STEREOISOMERISM;

EID: 33750474100     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0616052     Document Type: Article

References (14)

1. Cosford, N. D. P.; Bleicher, L.; Herbaut, A.; McCallum, J. S.; Vernier, J.-M.; Dawson, H.; Whitten, J. P.; Adams, P.; Chavez-Noriega, L.; Correa, L. D.; Crona, J. H.; Mahaffy, L. S.; Menzaghi, F.; Rao, T. S.; Reid, R.; Sacaan, A. I.; Santori, E.; Stauderman, K. A.; Whelan, K.; Lloyd, G. K.; McDonald, I. A. J. Med. Chem. 1996, 39, 3235-3237.
2. (a) Wang, D. X.; Booth, H.; Lerner-Marmarosh, N.; Osdene, T. S.; Abood, L. G. Drug Dev. Res. 1998, 45, 10.
3. (b) Cosford, N. D. P.; Bleicher, L. S.; Vernier, J.-M.; Chavez-Noriega, L.; Rao, T. S.; Siegel, R. S.; Suto, C.; Washburn, M.; Llyod, G. K.; McDonald, I. A. Pharm. Acta Helv. 2000, 74, 125.
4. Bleicher, L. S.; Cosford, N. D. P.; Herbaut, A.; McCallum, J. S.; McDonald, I. A. J. Org. Chem. 1998, 63, 1109-1118.
5. (a) Felpin, F.-X.; Vo-Thanh, G.; Villiéras, J.; Lebreton, J. Tetrahedron: Asymmetry 2001, 12, 1121.
6. (b) Felpin, F.-X.; Bertrand, M.-J.; Lebreton, J. Tetrahedron 2002, 58, 7381.
7. (a) Comins, D. L.; Smith, E. D. Tetrahedron Lett. 2006, 47, 1449-1451.
8. (b) Smith, E. D.; Février, F. C.; Comins, D. L. Org. Lett. 2006, 8, 179-182.
9. (c) Comins, D. L.; Despagnet, E. U.S. Patent Application No. 10/925, 516.
10. (a) Février, F. C.; Smith, E. D.; Comins, D. L. Org. Lett. 2005, 7, 5457.
11. (b) Comins, D. L.; Février, F. C.; Smith, E. D. U.S. Patent No. 7,067,672.
12. (c) Wagner, F. F.; Comins, D. L. Eur. J. Org. Chem. 2006, 3562.
13. (d) Comins, D. L.; Février, F. C.; Ondachi, P. W. U.S. Provisional Application No. 60/787,116.
14. Cosford, N. D. P.; Bleicher, L.; Vernier, J.-M.; Chavez-Noriega, L.; Rao, T. S.; Siegel, R. S.; Suto, C.; Washburn, M.; Lloyd, G. K.; McDonald, I. A. Pharm. Acta Helv. 2000, 74, 125.